Dr Samuel W Golden

Pittsburgh, Pennsylvania 15218

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible) — Completed